BLASUBCUTANEOUSINJECTABLE
Approved
Mar 2004
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
15
Data completeness
2/8 — Basic
Drug data last refreshed 21h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
GONAL-F (follitropin alfa/beta) is a recombinant human follicle-stimulating hormone (FSH) used to stimulate ovarian follicle development in women undergoing assisted reproductive technology (ART) and to treat hypogonadism in men. It is administered subcutaneously as an injectable biologic that mimics the body's natural FSH to promote fertility.
LOE Approaching
Product approaching loss of exclusivity with moderate competitive pressure (30/100), signaling transition from growth to defensive positioning and potential team restructuring.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Clinical Trials (15)
Study on the Pharmacokinetics and Safety of QL1012D and Gonal-F® in Healthy Female Volunteers
Started Apr 2025
48 enrolled
Infertility, Female
A Randomised Trial Comparing the Ovarian Response of a Starting Dose of Either 10 μg or 15 μg Follitropin Delta (FE 999049) to a Starting Dose of Either 150 IU or 225 IU Follitropin Alfa (GONAL-F) in Conventional Regimens in China
Started Mar 2024
301 enrolled
Infertility, Female
A Trial to Compare the Ovarian Response of REKOVELLE and GONAL-F in Conventional Dosing in Women Undergoing Controlled Ovarian Stimulation
Started Jul 2022
302 enrolled
Infertility
Low-dose Gonal-f® in Ovulation Induction
Started Jul 2013
24 enrolled
InfertilityMonofollicular Development
A Trial to Compare the Efficacy and Safety of Ovarian Stimulation With GONAL-f® and Luveris® Starting on Day 1 Versus Day 6 in Women Undergoing Assisted Reproductive Technique
Started May 2012
174 enrolled
InfertilityFertilityFollicle Stimulating Hormone Deficiency
Worked on GONAL-F at Merck & Co.? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.